Abstract
Introduction: The EQ-5D-Y-3L is a generic measure of health-related quality of life in children and adolescents. Although the Brazilian-Portuguese EQ-5D-Y-3L version is available, there is no value set for it, hampering its use in economic evaluations. This study aimed to elicit a Brazilian EQ-5D-Y-3L value set based on preferences of the general adult population. Methods: Two independent samples of adults participated in an online discrete choice experiment (DCE) survey and a composite time trade-off (cTTO) face-to-face interview. The framing was “considering your views for a 10-year-old child”. DCE data were analyzed using a mixed-logit model. The 243 DCE predicted values were mapped into the observed 28 cTTO values using linear and non-linear mapping approaches with and without intercept. Mapping approaches’ performance was assessed to estimate the most valid method to rescale DCE predicted values using the model fit (R2), Akaike Information Criteria (AIC), root mean squared error (RMSE), and mean absolute error (MAE). Results: A representative sample of 1376 Brazilian adults participated (DCE, 1152; cTTO, 211). The linear mapping without intercept (R2 = 96%; AIC, − 44; RMSE, 0.0803; MAE, − 0.0479) outperformed the non-linear without intercept (R2 = 98%; AIC, − 63; RMSE, 0.1385; MAE, − 0.1320). Utilities ranged from 1 (full health) to − 0.0059 (the worst health state). Highest weights were assigned to having pain or discomfort (pain/discomfort), followed by walking about (mobility), looking after myself (self-care), doing usual activities (usual activities), and feeling worried, sad, or unhappy (anxiety/depression). Conclusion: This study elicited the Brazilian EQ-5D-Y-3L value set using a mixed-logit DCE model with a power parameter based on a linear mapping without intercept, which can be used to estimate the quality-adjusted life-years for economic evaluations of health technologies targeting the Brazilian youth population.
Original language | English |
---|---|
Pages (from-to) | 1047-1063 |
Number of pages | 17 |
Journal | PharmacoEconomics |
Volume | 42 |
Issue number | 9 |
Early online date | 2 Jul 2024 |
DOIs | |
Publication status | Published - Sept 2024 |
Bibliographical note
Publisher Copyright:© The Author(s) 2024.
Funding
This study was funded by the EuroQol Research Foundation (220-VS). Caique de Melo do Espirito Santo was granted PhD scholarship from the Sao Paulo Research Foundation (FAPESP)\u2014process number 2021/08776-4; Ver\u00F4nica Souza Santos was granted a PhD scholarship from the Sao Paulo Research Foundation (FAPESP)\u2014process number 2019/12049-0; and Ti\u00EA Parma Yamato received a research grant from the Sao Paulo Research Foundation (FAPESP)\u2014process number 2017/17484-1. The funding agencies (the EuroQol Research Foundation and the Sao Paulo Research Foundation\u2014FAPESP) of this study had no influence on the design of the study and collection, analysis, and interpretation of data and writing of the manuscript.
Funders | Funder number |
---|---|
EuroQol Research Foundation | 220-VS |
Fundação de Amparo à Pesquisa do Estado de São Paulo | 2021/08776-4, 2019/12049-0 |
Tiê Parma Yamato | 2017/17484-1 |